Browse by Person

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 4.

Phillips, Andrew N, Bansi-Matharu, Loveleen, Venter, Francois et al. (22 more authors) (2020) Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa : modelling to inform treatment guidelines. The Lancet HIV. ISSN 2405-4704

Phillips, Andrew, Venter, Francois, Havlir, Diana et al. (21 more authors) (2018) Risks and benefits for use of dolutegravir-based antiretroviral drug regimens in sub Saharan Africa: a modelling study. The Lancet HIV. pp. 1-12. ISSN 2405-4704

Phillips, Andrew N, Cambiano, Valentina, Nakagawa, Fumiyo et al. (22 more authors) (2017) Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa : a modelling study. Lancet HIV. pp. 1-9.

Phillips, Andrew N, Stover, John, Cambiano, Valentina et al. (6 more authors) (2017) Impact of HIV drug resistance on HIV/AIDS associated mortality, new infections and antiretroviral therapy program costs in sub-Saharan Africa. The Journal of Infectious Diseases. ISSN 0022-1899

This list was generated on Sun Aug 9 13:34:46 2020 BST.